Tandem Diabetes Care INC Form 4 insider transactions

Mark Novara, EVP & Chief Commercial Officer of Tandem Diabetes Care, reports the vesting of restricted stock units and subsequent tax withholding.

Rick Carpenter, Chief Technology Officer of Tandem Diabetes Care, reports the vesting of restricted stock units and subsequent withholding of shares for tax obligations.

Jean-Claude Kyrillos, EVP & Chief Operating Officer of Tandem Diabetes Care Inc., reports purchasing 10,538 shares of common stock at a weighted average price of $18.1217.

Susan Morrison, EVP & Chief Admin. Officer of Tandem Diabetes Care, exercised performance stock units and disposed of shares to cover tax withholding requirements on February 25, 2025.

Leigh Vosseller, EVP & CFO of Tandem Diabetes Care, reports the vesting and subsequent tax withholding of performance stock units.

Elizabeth Gasser, EVP and Chief Strategy Officer of Tandem Diabetes Care, reports the vesting and tax withholding of performance stock units.

John F. Sheridan, CEO of Tandem Diabetes Care, reports the vesting and subsequent tax withholding of performance stock units.

EVP and Chief Strategy Officer of Tandem Diabetes Care, Elizabeth Anne Gasser, reports the vesting of restricted stock units and related tax withholding.

Shannon Hansen, EVP & Chief Legal Officer of Tandem Diabetes Care, reports the vesting of restricted stock units and subsequent tax withholding.

EVP & Chief Admin. Officer of Tandem Diabetes Care, Susan Morrison, reports the vesting of restricted stock units and subsequent tax withholding, resulting in a net increase in her holdings of common stock.

John F. Sheridan, President and CEO of Tandem Diabetes Care, reports the vesting and subsequent tax withholding of shares related to restricted stock units.

Leigh Vosseller, EVP & CFO of Tandem Diabetes Care, reports the vesting and tax-related withholding of restricted stock units.

Rick Carpenter, Chief Technology Officer of Tandem Diabetes Care, reports the vesting of restricted stock units and subsequent tax withholding.

Mark David Novara, EVP & Chief Commercial Officer at Tandem Diabetes Care, exercised stock options and sold shares to cover tax obligations on December 16, 2024.

Rick Carpenter, Chief Technology Officer at Tandem Diabetes Care, reported the vesting of restricted stock units and the subsequent withholding of shares for tax purposes.

Director Kim D. Blickenstaff sold a total of 40,000 shares of Tandem Diabetes Care stock in two transactions on November 20 and 21, 2024.

Mark David Novara, EVP & Chief Commercial Officer of Tandem Diabetes Care, acquired 532 shares of common stock through the company's Employee Stock Purchase Plan.

Tandem Diabetes Care's Chief Technology Officer, Rick Carpenter, reports the acquisition and disposal of company stock and restricted stock units.

Susan Morrison, EVP & Chief Admin. Officer at Tandem Diabetes Care, reports the vesting and tax withholding of restricted stock units.

EVP & Chief Legal Officer of Tandem Diabetes Care, Shannon Hansen, reports multiple transactions involving company stock, including the vesting of restricted stock units and purchases through the employee stock purchase plan.

EVP and Chief Financial Officer of Tandem Diabetes Care, Leigh Vosseller, reports the vesting of restricted stock units and associated tax withholdings.

Tandem Diabetes Care CEO John Sheridan reports the acquisition of shares through stock options and an employee stock purchase plan, along with the withholding of shares for tax purposes.

Elizabeth Anne Gasser, EVP and Chief Strategy Officer at Tandem Diabetes Care, reports multiple transactions involving company stock, including acquisitions through stock plans and tax withholdings.

Rick Carpenter, Chief Technology Officer of Tandem Diabetes Care, reports the vesting of restricted stock units and subsequent withholding of shares for tax obligations.

EVP & Chief Legal Officer of Tandem Diabetes Care, Shannon Marie Hansen, reports acquisition and disposal of common stock and restricted stock units.

Rick Carpenter, Chief Technology Officer of Tandem Diabetes Care, reports the vesting and tax withholding of restricted stock units.

John F. Sheridan, CEO of Tandem Diabetes Care, reports the vesting and tax withholding of restricted stock units, resulting in adjustments to his holdings of common stock.

EVP and Chief Strategy Officer Elizabeth Gasser reports acquisition and disposal of Tandem Diabetes Care stock and restricted stock units due to vesting and tax withholding.

EVP & Chief Admin. Officer Susan Morrison reports the vesting of restricted stock units and subsequent withholding of shares for tax obligations.

EVP and CFO of Tandem Diabetes Care, Leigh Vosseller, reports the vesting of restricted stock units and subsequent tax withholding, resulting in changes to beneficial ownership of common stock.